Nurix Therapeutics (NRIX) Q3 2024 Earnings

11JulConfirmed
Q3 2023
Q4 2023
Q1 2024
Q3 2024
-0.78
-0.71
-0.64
-0.57

Details

Expected EPS
-0.63475
Actual EPS
-0.71
Surprise EPS
-0.08
Surprise Percent
+11.86%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.71 per share for Q3 2024.

0 Comments

Share your thoughts